Alembic Pharmaceuticals Ltd announces Successful completion of USFDA inspection at Derma Facility at Karakhadi

Alembic Pharmaceuticals Limited has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Derma Facility located at Karakhadi without any observations. The inspection was conducted from 6th March, 2023 to 10th March, 2023.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 499.30 as compared to the previous close of Rs. 504.70. The total number of shares traded during the day was 3064 in over 490 trades.

The stock hit an intraday high of Rs. 508.50 and intraday low of 494.45. The net turnover during the day was Rs. 1533190.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 USFDA Inspection DermaFacility Karakhadi ZeroObservations